(Q58064931)

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

The role of the T3/antigen receptor complex in T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Identification of a novel 45-kDa cell surface molecule involved in activation of the human Jurkat T cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

A novel 90-kDa polypeptide (Tp90) possibly involved in an antigen-independent pathway of T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Human T lymphocyte antigens as defined by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Anticlonotypic monoclonal antibodies induce proliferation of clonotype-positive T cells in peripheral blood human T lymphocytes. Evidence for a phenotypic (T4/T8) heterogeneity of the clonotype-positive proliferating cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Involvement of the CD4 molecule in a post-activation event on T cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Selection and characterization of monoclonal antibodies to the idiotype-like structure of an interleukin-2-producing human leukemia t-cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021

Human cytolytic cell clones lacking surface expression of T cell receptor alpha/beta or gamma/delta. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190528

7 January 2021